Medincell Says Teva Raises 2026 UZEDY Sales Forecast to $290 Million-$310 Million
Bitget2026/11/03 12:34- Medincell partner Teva raised its 2026 UZEDY sales forecast to $290 million–$310 million from $270 million–$290 million.
- Third-quarter US net sales reached $85 million, up 96% year over year.
- Nine-month US net sales totaled $225 million, exceeding full-year 2025 sales of $191 million.
- Medincell receives mid- to high-single-digit royalties on net sales and is eligible for $105 million in sales-based milestone payments.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Justin Sun Expects a Drop in Bitcoin — Details of the One-Hour Meeting Have Emerged
From "selling subscriptions" to "selling results": Adobe (ADBE.US) experiments with weekly billing for Acrobat, BTIG says growth sustainability remains to be verified
At the MAX conference held last week, Adobe unveiled new Agentic AI tools and previewed the upcoming local MCP (Model Context Protocol) integration. This feature will allow creators to directly access third-party agents within Photoshop, Illustrator, Premiere, and After Effects.
AI investment boom leads to job growth only at construction sites
Crypto prices
More
